Award
National Cancer Institute 3R01CA164719-12S2
Anti-cancer vaccine targeting the host-parasite interface during fluke infection
Recipient
Not specified
Award Amount
$139,050.00
Ceiling
$139,050.00
Awarded
September 19, 2025
Identifier
3R01CA164719-12S2
NIH grant awarded for research on an anti-cancer vaccine targeting the host-parasite interface during fluke infection, focusing on proteins of Opisthorchis viverrini linked to cholangiocarcinoma, with testing in rodent models.
Description
This NIH grant supports research on developing an anti-cancer vaccine targeting proteins essential to the parasite Opisthorchis viverrini, which is associated with cholangiocarcinoma in East Asia. The project involves exploring key proteins involved in host-parasite communication and testing vaccine efficacy in rodent models.